Enovix (ENVX) Valuation Revisited As Laser Dicing Setbacks Temper Analyst Expectations

Why laser dicing issues put Enovix (ENVX) in the spotlight

Enovix (ENVX) has been drawing attention after several analysts flagged laser dicing problems that are affecting production yields, slowing battery qualification for a key customer and prompting reduced expectations despite continued positive ratings.

See our latest analysis for Enovix.

Those manufacturing concerns have been reflected in Enovix’s share price, with a 30 day share price return showing a 19.41% decline and a 90 day share price return showing a 42.82% decline. The 1 year total shareholder return is 35.42% lower, indicating fading momentum despite recent positive commentary on its technology and customer pipeline.

If the laser dicing issues have you reassessing battery exposure, it may be worth scanning other opportunities through our list of 61 profitable AI stocks that aren't just burning cash as a potential next step.

With Enovix shares down sharply over the past year, trading at US$4.94 and sitting at a large discount to analyst targets and some intrinsic value estimates, you have to ask: is this a reset buying opportunity, or is the market already pricing in future growth?

Most Popular Narrative: 68% Undervalued

With Enovix last closing at $4.94 against a widely followed fair value estimate of about $15.39, the current price sits well below that narrative view and puts the focus squarely on whether execution can catch up to expectations.

• Completion of the site acceptance testing for the high volume manufacturing line in Malaysia is set to boost production capacity and support significant revenue growth with a focus on readiness for smartphone mass production in the fourth quarter of 2025.
• Successful shipment of early engineering smartphone battery samples and positive safety test results indicate future revenue increase potential, pending successful customer qualification for anticipated commercial smartphone launches in 2025.

Read the complete narrative.

Want to see what is baked into that fair value gap? The narrative leans on rapid revenue expansion, improving margins and a future earnings profile that looks very different to today. The full set of assumptions might surprise you.

Result: Fair Value of $15.39 (UNDERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, there is still real execution risk. Laser dicing challenges and high capital spending for new manufacturing lines are both capable of derailing the current upside narrative.

Find out about the key risks to this Enovix narrative.

Another View: Multiples Paint a Very Different Picture

DCF work suggests Enovix could be undervalued, with our model pointing to a fair value of about $14.98 versus the current $4.94 share price. However, on revenue multiples it looks stretched, trading on a P/S of 32.9x versus 2.3x for the US Electrical industry and 17x for peers, while the fair ratio sits at 3.6x. That gap raises a simple question for you: is the market underestimating future cash flows or overestimating today’s sales?

See what the numbers say about this price — find out in our valuation breakdown.

Next Steps

If this mix of concern and optimism around Enovix feels hard to weigh, take a moment to review the data yourself and decide where you stand. Then use our breakdown of 2 key rewards and 1 important warning sign to see how those factors line up for your own thesis.

Looking for more investment ideas?

If Enovix has you rethinking your next move, do not stop here. Broaden your watchlist with ideas that match the kind of portfolio you want to build.

• Target potential value opportunities by scanning our list of 48 high quality undervalued stocks that pair quality fundamentals with prices that may not fully reflect their profiles.
• Strengthen your income stream by reviewing 14 dividend fortresses, focused on companies offering higher yields with an emphasis on durability.
• Sleep a little easier by checking out 68 resilient stocks with low risk scores, highlighting businesses that score well on lower risk profiles and financial resilience.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com